Celldex Announces Planned Transition Of Chief Financial Officer
CLDX•Planned CFO transition
July 15 (Reuters) - Celldex Therapeutics Inc. CLDX.O:
- Celldex announces planned transition of chief financial officer
- Celldex Therapeutics said CFO Sam Martin plans to retire in 2027
- Celldex began a search for a new CFO; Sam Martin will remain through March 2027




